Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Maryam Akbari, Hossein Heli, Ahmad Oryan & Gholamreza Hatam. (2023) A novel outlook in the delivery of artemisinin: production and efficacy in experimental visceral leishmaniasis. Pathogens and Global Health 0:0, pages 1-7.
Read now
Read now
Muzamil Yaqub Want, Priya Yadav, Rakin Khan, Garima Chouhan, Mohammad Islamuddin, Sheka Yagub Aloyouni, Asoke P Chattopadhyay, Suliman Yousef AlOmar & Farhat Afrin. (2021) Critical Antileishmanial in vitro Effects of Highly Examined Gold Nanoparticles. International Journal of Nanomedicine 16, pages 7285-7295.
Read now
Read now
Kevin Matha, Brice Calvignac, Jean-Pierre Gangneux & Jean-Pierre Benoit. (2021) The advantages of nanomedicine in the treatment of visceral leishmaniasis: between sound arguments and wishful thinking. Expert Opinion on Drug Delivery 18:4, pages 471-487.
Read now
Read now
Mangat Singh, Shanti Devi, Virendra S. Rana, Bhuwan B. Mishra, Jitendra Kumar & Vivek Ahluwalia. (2019) Delivery of phytochemicals by liposome cargos: recent progress, challenges and opportunities. Journal of Microencapsulation 36:3, pages 215-235.
Read now
Read now
Ives Charlie-Silva, Leonardo Fernandes Fraceto & Nathalie Ferreira Silva de Melo. (2018) Progress in nano-drug delivery of artemisinin and its derivatives: towards to use in immunomodulatory approaches. Artificial Cells, Nanomedicine, and Biotechnology 46:sup3, pages 611-620.
Read now
Read now
M. Junaid Dar, Fakhar Ud Din & Gul Majid Khan. (2018) Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell. Drug Delivery 25:1, pages 1595-1606.
Read now
Read now
Articles from other publishers (44)
Audrey R.S.T. Silva, Amanda M.B. Costa, Sona Jain, Patrícia Severino, Ricardo Scher, Rogéria S. Nunes, Eliana B. Souto & Silvio S. Dolabella. (2023) 3-Carene-loaded poloxamer micelles against Leishmania: Development, characterization and in vitro proof-of-concept. Journal of Drug Delivery Science and Technology 82, pages 104376.
Crossref
Crossref
Mariana Elizabeth Troncoso, María José Germanó, Victoria J. Arrieta, María Fernanda García Bustos, Diego Cifuente, Diego E. Cargnelutti & Esteban S. Lozano. (2023)
Antiparasitic Activity of Two Natural Terpenes from
Salvia cuspidata
against
Leishmania amazonensis
. Journal of Natural Products.
Crossref
Crossref
Sutherland Kester Maciver, Sumayah Abdelnasir, Ayaz Anwar, Ruqaiyyah Siddiqui & Naveed Ahmed Khan. (2023) Modular nanotheranostic agents for protistan parasitic diseases: Magic bullets with tracers. Molecular and Biochemical Parasitology 253, pages 111541.
Crossref
Crossref
Deepak Gupta, Pankaj K. Singh, Pavan K. Yadav, Tadigoppula Narender, Umesh K. Patil, Sanjay K. Jain & Manish K. Chourasia. (2023) Emerging strategies and challenges of molecular therapeutics in antileishmanial drug development. International Immunopharmacology 115, pages 109649.
Crossref
Crossref
Adithyan Jayaraman, Sujatha Srinivasan, Amrita Kar, B.S. Harish, Mamilla R. Charan Raja, Kiran Babu Uppuluri & Santanu Kar Mahapatra. (2022) Oceanimonas sp. BPMS22-derived protein protease inhibitor induces anti-leishmanial immune responses through macrophage M2 to M1 repolarization. International Immunopharmacology 112, pages 109281.
Crossref
Crossref
Felipe Francisco Tuon, Leticia Ramos Dantas, Regina Maia de Souza, Victoria Stadler Tasca Ribeiro & Valdir Sabbaga Amato. (2022) Liposomal drug delivery systems for the treatment of leishmaniasis. Parasitology Research 121:11, pages 3073-3082.
Crossref
Crossref
Xiamin Cheng, Hui Yan, Songhao Pang, Mingjun Ya, Feng Qiu, Pinzhu Qin, Chao Zeng & Yongna Lu. (2022) Liposomes as Multifunctional Nano-Carriers for Medicinal Natural Products. Frontiers in Chemistry 10.
Crossref
Crossref
Atif Ullah Khan, Humzah Jamshaid, Fakhar ud Din, Alam Zeb & Gul Majid Khan. (2022) Designing, Optimization and Characterization of Trifluralin Transfersomal Gel to Passively Target Cutaneous Leishmaniasis. Journal of Pharmaceutical Sciences 111:6, pages 1798-1811.
Crossref
Crossref
Sooyoung Shin, Soonbum Kwon & Yoon Yeo. (2022) Meta-Analysis of Drug Delivery Approaches for Treating Intracellular Infections. Pharmaceutical Research 39:6, pages 1085-1114.
Crossref
Crossref
Vagner Dias Raimundo, Renner Philipe Rodrigues Carvalho, Mariana Machado-Neves & Eduardo de Almeida Marques-da-Silva. (2022) Effects of terpenes in the treatment of visceral leishmaniasis: A systematic review of preclinical evidence. Pharmacological Research 177, pages 106117.
Crossref
Crossref
Débora V.C. Mendonça, Grasiele S.V. Tavares, Isabela A.G. Pereira, João A. Oliveira-da-Silva, Fernanda F. Ramos, Daniela P. Lage, Amanda S. Machado, Lívia M. Carvalho, Thiago A.R. Reis, Ana Maria R.S. Carvalho, Flaviano M. Ottoni, Fernanda Ludolf, Camila S. Freitas, Vívian T. Martins, Miguel A. Chávez-Fumagalli, Mariana C. Duarte, Maria V. Humbert, Bruno M. Roatt, Daniel Menezes-Souza, Ricardo J. Alves & Eduardo A.F. Coelho. (2022) Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study. Experimental Parasitology 233, pages 108205.
Crossref
Crossref
Pragya Prasanna, Prakash Kumar, Saurabh Kumar, Vinod Kumar Rajana, Vishnu Kant, Surendra Rajit Prasad, Utpal Mohan, V. Ravichandiran & Debabrata Mandal. (2021) Current status of nanoscale drug delivery and the future of nano-vaccine development for leishmaniasis – A review. Biomedicine & Pharmacotherapy 141, pages 111920.
Crossref
Crossref
Olga Kammona & Evgenia Tsanaktsidou. (2021) Nanotechnology-aided diagnosis, treatment and prevention of leishmaniasis. International Journal of Pharmaceutics 605, pages 120761.
Crossref
Crossref
Marcela Tavares Luiz, Juliana Santos Rosa Viegas, Juliana Palma Abriata, Felipe Viegas, Fabiana Testa Moura de Carvalho Vicentini, Maria Vitória Lopes Badra Bentley, Marlus Chorilli, Juliana Maldonado Marchetti & Delia Rita Tapia-Blácido. (2021) Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics 165, pages 127-148.
Crossref
Crossref
Simone SC Oliveira, Carine S Ferreira, Marta H Branquinha, André LS Santos, Marco V Chaud, Sona Jain, Juliana C Cardoso, Anđelka B Kovačević, Eliana B Souto & Patrícia Severino. (2020) Overcoming multi‐resistant leishmania treatment by nanoencapsulation of potent antimicrobials. Journal of Chemical Technology & Biotechnology 96:8, pages 2123-2140.
Crossref
Crossref
Eleftherios Halevas, Barbara Mavroidi, Chrysoula Kokotidou, Anna Mitraki, Maria Pelecanou & Marina Sagnou. (2021) Advanced bis-MPA hyperbranched dendritic nanocarriers of artemisinin with anticancer potential. Journal of Nanoparticle Research 23:7.
Crossref
Crossref
Swapnil Mehta, Sanjay Kulkarni, Ajinkya N. Nikam, Bharat S. Padya, Abhijeet Pandey & Srinivas Mutalik. (2021) Liposomes as Versatile Platform for Cancer Theranostics: Therapy, Bio-imaging, and Toxicological Aspects. Current Pharmaceutical Design 27:17, pages 1977-1991.
Crossref
Crossref
Brindha J, Balamurali M. M & Kaushik Chanda. (2021) An Overview on the Therapeutics of Neglected Infectious Diseases—Leishmaniasis and Chagas Diseases. Frontiers in Chemistry 9.
Crossref
Crossref
S. Alven & B.A. Aderibigbe. 2021. Applications of Nanobiotechnology for Neglected Tropical Diseases. Applications of Nanobiotechnology for Neglected Tropical Diseases
191
216
.
Camila S. Freitas, João A. Oliveira-da-Silva, Daniela P. Lage, Rafaella R. Costa, Débora V. C. Mendonça, Vívian T. Martins, Thiago A. R. Reis, Luciana M. R. Antinarelli, Amanda S. Machado, Grasiele S. V. Tavares, Fernanda F. Ramos, Vinicio T. S. Coelho, Rory C. F. Brito, Fernanda Ludolf, Miguel A. Chávez-Fumagalli, Bruno M. Roatt, Gabriela S. Ramos, Jennifer Munkert, Flaviano M. Ottoni, Priscilla R. V. Campana, Maria V. Humbert, Elaine S. Coimbra, Fernão C. Braga, Rodrigo M. Pádua & Eduardo A. F. Coelho. (2020) Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis. Parasitology Research 120:1, pages 321-335.
Crossref
Crossref
Hacène Medkour, Idir Bitam, Younes Laidoudi, Ismail Lafri, Abdelaziz Lounas, Hamza Karim Hamidat, Abdeslam Mekroud, Marie Varloud, Bernard Davoust & Oleg Mediannikov. (2020) Potential of Artesunate in the treatment of visceral leishmaniasis in dogs naturally infected by Leishmania infantum: Efficacy evidence from a randomized field trial. PLOS Neglected Tropical Diseases 14:12, pages e0008947.
Crossref
Crossref
Xinchi Feng, Shijie Cao, Feng Qiu & Boli Zhang. (2020) Traditional application and modern pharmacological research of Artemisia annua L.. Pharmacology & Therapeutics 216, pages 107650.
Crossref
Crossref
Giuliana Muraca, Ignacio Rivero Berti, María L. Sbaraglini, Wagner J. Fávaro, Nelson Durán, Guillermo R. Castro & Alan Talevi. (2020) Trypanosomatid-Caused Conditions: State of the Art of Therapeutics and Potential Applications of Lipid-Based Nanocarriers. Frontiers in Chemistry 8.
Crossref
Crossref
Sushmita Ghosh, Aditya Verma, Vinay Kumar, Dibyabhaba Pradhan, Angamuthu Selvapandiyan, Poonam Salotra & Ruchi Singh. (2020) Genomic and Transcriptomic Analysis for Identification of Genes and Interlinked Pathways Mediating Artemisinin Resistance in Leishmania donovani. Genes 11:11, pages 1362.
Crossref
Crossref
Margherita Ortalli, Stefania Varani, Giorgia Cimato, Ruben Veronesi, Arianna Quintavalla, Marco Lombardo, Magda Monari & Claudio Trombini. (2020) Evaluation of the Pharmacophoric Role of the O–O Bond in Synthetic Antileishmanial Compounds: Comparison between 1,2-Dioxanes and Tetrahydropyrans. Journal of Medicinal Chemistry 63:21, pages 13140-13158.
Crossref
Crossref
Praveesh Valissery, Roshni Thapa, Jyoti Singh, Deepak Gaur, Jaydeep Bhattacharya, Agam Prasad Singh & Suman Kumar Dhar. (2020)
Potent
in vivo
antimalarial activity of water-soluble artemisinin nano-preparations
. RSC Advances 10:59, pages 36201-36211.
Crossref
Crossref
Supriya Khanra, Subir Kumar Juin, Junaid Jibran Jawed, Sweta Ghosh, Shreyasi Dutta, Shaik Abdul Nabi, Jyotirmayee Dash, Dipak Dasgupta, Subrata Majumdar & Rahul Banerjee. (2020) In vivo experiments demonstrate the potent antileishmanial efficacy of repurposed suramin in visceral leishmaniasis. PLOS Neglected Tropical Diseases 14:8, pages e0008575.
Crossref
Crossref
Sibusiso Alven & Blessing Atim Aderibigbe. (2020) Nanoparticles Formulations of Artemisinin and Derivatives as Potential Therapeutics for the Treatment of Cancer, Leishmaniasis and Malaria. Pharmaceutics 12:8, pages 748.
Crossref
Crossref
Aakriti Singh, Sandeep Sharma, Ganesh Yadagiri, Shabi Parvez, Ritika Gupta, Nitin Kumar Singhal, Nikhil Koratkar, Om Prakash Singh, Shyam Sundar, Vijayakumar Shanmugam & Shyam Lal Mudavath. (2020)
Sensible graphene oxide differentiates macrophages and
Leishmania
: a bio-nano interplay in attenuating intracellular parasite
. RSC Advances 10:46, pages 27502-27511.
Crossref
Crossref
Mohammad A. Ansari, Khan F. Badrealam, Asrar Alam, Saba Tufail, Gulshan Khalique, Mohammad J. Equbal, Mohammad A. Alzohairy, Ahmad Almatroudi, Mohammad N. Alomary & Faheem H. Pottoo. (2020) Recent Nano-based Therapeutic Intervention of Bioactive Sesquiterpenes: Prospects in Cancer Therapeutics. Current Pharmaceutical Design 26:11, pages 1138-1144.
Crossref
Crossref
Lília I. L. Cabral, Sébastien Pomel, Sandrine Cojean, Patrícia S. M. Amado, Philippe M. Loiseau & Maria L. S. Cristiano. (2020) Synthesis and Antileishmanial Activity of 1,2,4,5-Tetraoxanes against Leishmania donovani. Molecules 25:3, pages 465.
Crossref
Crossref
Amina Riaz, Naveed Ahmed, Muhammad Ijaz Khan, Ihsan-ul Haq, Asim ur Rehman & Gul Majid Khan. (2019) Formulation of topical NLCs to target macrophages for cutaneous leishmaniasis. Journal of Drug Delivery Science and Technology 54, pages 101232.
Crossref
Crossref
Maushmi S. Kumar, Tanuja T. Yadav, Rohan R. Khair, Godefridus J. Peters & Mayur C. Yergeri. (2019) Combination Therapies of Artemisinin and its Derivatives as a Viable Approach for Future Cancer Treatment. Current Pharmaceutical Design 25:31, pages 3323-3338.
Crossref
Crossref
Sujogya Kumar Panda, Luis Cláudio Nascimento da Silva, Dinkar Sahal & Marco Leonti. (2019) Editorial: Ethnopharmacological Studies for the Development of Drugs With Special Reference to Asteraceae. Frontiers in Pharmacology 10.
Crossref
Crossref
Aditya Verma, Sushmita Ghosh, Poonam Salotra & Ruchi Singh. (2019) Artemisinin-resistant Leishmania parasite modulates host cell defense mechanism and exhibits altered expression of unfolded protein response genes. Parasitology Research 118:9, pages 2705-2713.
Crossref
Crossref
Victoria Wagner, Aida Minguez-Menendez, Joan Pena & Christopher Fernández-Prada. (2019) Innovative Solutions for the Control of Leishmaniases: Nanoscale Drug Delivery Systems. Current Pharmaceutical Design 25:14, pages 1582-1592.
Crossref
Crossref
Bhawana Singh, Sanjay Varikuti, Gregory Halsey, Greta Volpedo, Omar M Hamza & Abhay R Satoskar. (2019) Host-directed therapies for parasitic diseases. Future Medicinal Chemistry 11:15, pages 1999-2018.
Crossref
Crossref
Om Prakash Singh, Mallikarjuna Rao Gedda, Shyam Lal Mudavath, Onkar Nath Srivastava & Shyam Sundar. (2019) Envisioning the innovations in nanomedicine to combat visceral leishmaniasis: for future theranostic application. Nanomedicine 14:14, pages 1911-1927.
Crossref
Crossref
Roberval Nascimento Moraes Neto, Ruth Flávia Barros Setúbal, Taciana Mirely Maciel Higino, Maria Carolina Accioly Brelaz-de-Castro, Luís Cláudio Nascimento da Silva & Amanda Silva dos Santos Aliança. (2019) Asteraceae Plants as Sources of Compounds Against Leishmaniasis and Chagas Disease. Frontiers in Pharmacology 10.
Crossref
Crossref
Sritama De Sarkar, Deblina Sarkar, Avijit Sarkar, Aishwarya Dighal, Sasanka Chakrabarti, Katrin Staniek, Lars Gille & Mitali Chatterjee. (2018) The leishmanicidal activity of artemisinin is mediated by cleavage of the endoperoxide bridge and mitochondrial dysfunction. Parasitology 146:4, pages 511-520.
Crossref
Crossref
Kofi Dadzie Kwofie, Kai Sato, Chizu Sanjoba, Akina Hino, Rieko Shimogawara, Michael Amoa-Bosompem, Irene Ayi, Daniel A. Boakye, Abraham K. Anang, Kyung-Soo Chang, Mitsuko Ohashi, Hye-Sook Kim, Nobuo Ohta, Yoshitsugu Matsumoto & Shiroh Iwanaga. (2019) Oral activity of the antimalarial endoperoxide 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol (N-251) against Leishmania donovani complex. PLOS Neglected Tropical Diseases 13:3, pages e0007235.
Crossref
Crossref
Sara Napooni, Mohsen Arbabi, Mahdi Delavari, Hossein Hooshyar & Sima Rasti. (2018) Lethal effects of gold nanoparticles on protoscolices of hydatid cyst: in vitro study. Comparative Clinical Pathology 28:1, pages 143-150.
Crossref
Crossref
Ana Beatriz C. Santos-Valle, Gabriela R.R. Souza, Camila Q. Paes, Takuya Miyazaki, Adny Henrique Silva, Maria J. Altube, Maria J. Morilla, Eder L. Romero, Tânia B. Creczynski-Pasa, Horacio Cabral & Frederico Pittella. (2019) Nanomedicine strategies for addressing major needs in neglected tropical diseases. Annual Reviews in Control 48, pages 423-441.
Crossref
Crossref
Sanjay Varikuti, Bijay Kumar Jha, Greta Volpedo, Nathan M. Ryan, Gregory Halsey, Omar M. Hamza, Bradford S. McGwire & Abhay R. Satoskar. (2018) Host-Directed Drug Therapies for Neglected Tropical Diseases Caused by Protozoan Parasites. Frontiers in Microbiology 9.
Crossref
Crossref